000 | 01543 a2200421 4500 | ||
---|---|---|---|
005 | 20250512001304.0 | ||
264 | 0 | _c19860923 | |
008 | 198609s 0 0 eng d | ||
022 | _a0730-0077 | ||
024 | 7 |
_a10.3109/10641968609039608 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBall, D | |
245 | 0 | 0 |
_aVeratridine, angiotensin receptors and aldosteronogenesis in bovine adrenal glomerulosa cells. _h[electronic resource] |
260 |
_bClinical and experimental hypertension. Part A, Theory and practice _c1986 |
||
300 |
_a323-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenal Cortex _xdrug effects |
650 | 0 | 4 |
_aAldosterone _xbiosynthesis |
650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aCevanes _xpharmacology |
650 | 0 | 4 |
_aIon Channels _xdrug effects |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aOuabain _xpharmacology |
650 | 0 | 4 |
_aReceptors, Angiotensin _xdrug effects |
650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
650 | 0 | 4 |
_aSodium _xmetabolism |
650 | 0 | 4 |
_aVeratridine _xpharmacology |
650 | 0 | 4 |
_aVeratrine _xanalogs & derivatives |
700 | 1 | _aElliott, M E | |
700 | 1 | _aHadjokas, N | |
700 | 1 | _aGoodfriend, T L | |
700 | 1 | _aGreen, M J | |
773 | 0 |
_tClinical and experimental hypertension. Part A, Theory and practice _gvol. 8 _gno. 3 _gp. 323-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10641968609039608 _zAvailable from publisher's website |
999 |
_c2432072 _d2432072 |